@article {993, title = {In-silico Molecular Docking Studies of some Isolated Phytochemicals from Biophytum veldkampii against Cyclooxygenase-II Enzyme and in vivo Anti-inflammatory Activity}, journal = {Pharmacognosy Research}, volume = {13}, year = {2021}, month = {October 2021}, pages = {192-198}, type = {Original Article}, chapter = {192}, abstract = {

Background: The current study estimate the anti-inflammatory activity of whole plant of Biophytum veldkampii on carageenan induced inflammation on rats compiled by molecular docking studies of phytocompounds from the plants with Cyclooxygenase II (PDB ID: 3LN1). Methods: In this research Biophytum veldkampii was subjected to extraction using methanol. In-vivo anti-inflammatory activity was assessed by using carageenan induced inflammation on rats and in-silico molecular docking studies was performed by using of Autodock 4.0. Results: The outcomes revealed that the methanolic extract has most prominenant anti-inflammatory activity at various doses. Among all the substances 2,6,3{\textquoteright},4{\textquoteright}-Tetrahydroxy-2-benzylcoumaranone revealed the most effective docking rating of -6.8, which is near to Diclofenac, i.e. - 6.9, ensuring that 2,6,3{\textquoteright},4{\textquoteright}-Tetrahydroxy-2-benzylcoumaranone has a strong binding fondness in between protein and ligand. Conclusion: From the results, a conclusion can be drawn that the anti-inflammatory activity of Biophytum veldkampii in both in vivo and in silico methods. This information sustains 2,6,3{\textquoteright},4{\textquoteright}-Tetrahydroxy-2-benzylcoumaranone to be a useful anti-inflammatory compound beneficial to future clinical studies.

}, keywords = {2, 3{\textquoteright}, 4{\textquoteright}-Tetrahydroxy-2 benzylcoumaranone, 6, Autodock4.0, Carageenan, Cyclooxygenase II, In-silico, Inflammation, Phytochemical}, doi = {10.5530/pres.13.4.11}, author = {Nagaraju Bandaru and D.S.N.B.K Prasanth and A.Rajasekhar Reddy and G.S.N Koteswara Rao and Kumar V.S Nemmani and Alla Narayana Rao} } @article {97, title = {Neuroprotective and Antioxidant Activities of Fraction Isolated from Methanolic Extract of Sapindus laurifolia on Scopolamine Induced Dementia}, journal = {Pharmacognosy Research}, volume = {12}, year = {2020}, month = {May 2020}, pages = {119-126}, type = {Original Article}, chapter = {119}, abstract = {

Background: Phytotherapy is considered a complementary approach for preventing and treating many diseases. Plants are rich source of bioactive secondary metabolites of a wide variety such as saponins, tannins, terpenoids, alkaloids, and flavonoids. Sapindus laurifolia (fam: Sapindaceae), well known as soapnuts, are used medicinally as an expectorant, emetic, contraceptive, and for treatment of excessive salivation, epilepsy, chlorosis, and migraines. Objective: To isolation of fractions, estimation of total flavonoid content, in vitro antioxidant and in vivo neuroprotective activity of S. laurifolia fruit kernel. Materials and Methods: In this study, in vitro antioxidant activity is estimated by 2,2-diphenyl-1-picrylhydrazyl assay method. Neuroprotective activity is estimated by scopolamine-induced dementia method. In neuroprotective method, behavioral parameters were checked by escape latency (EL) time (s) by using the Morris water maze, active avoidance testing using elevated plus maze, and neurochemicals such as glutathione, catalase (CAT), superoxide dismutase (SOD), and Cholinesterase were estimated. Results: In scopolamine-induced dementia, increased EL time, active avoidance and neurochemicals such as glutathione, CAT, SOD and cholinesterase decreased. Whereas standard and Fraction S-treated animals decreased in EL time, active avoidance and increased locomotor activity, neurochemicals such as glutathione, CAT, SOD, and cholinesterase also increased. Conclusion: The present study clearly demonstrates that methanolic extract of S. laurifolia Fraction A (50 and 100 mg/kg) kernel significantly attenuate scopolamine-induced dementia by improving the learning, memory, antioxidant potentiality, and anti-acetyl cholinesterase activity. Therefore, this Fraction A can be a potential novel therapeutic strategy for controlling neurodegenerative dementia especially Alzheimer{\textquoteright}s disease. Yet, advance studies are needed to characterize the active compound(s) and expose the possible mechanism of action.

}, keywords = {Antioxidant, Dementia, Isolation, Neuroprotective, Sapindus}, doi = {10.4103/pr.pr_50_19}, author = {Nagaraju Bandaru and A Ramu and S Vidhyadhara} }